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Abstract
The field of phenomics has been investigating network structure among large arrays of
phenotypes, and genome-wide association studies (GWAS) have been used to investigate the
relationship between genetic variation and single diseases/outcomes. A novel approach has
emerged combining both the exploration of phenotypic structure and genotypic variation, known
as the phenome-wide association study (PheWAS). The Population Architecture using Genomics
and Epidemiology (PAGE) network is a National Human Genome Research Institute (NHGRI)-
supported collaboration of four groups accessing eight extensively characterized epidemiologic
studies. The primary focus of PAGE is deep characterization of well-replicated GWAS variants
and their relationships to various phenotypes and traits in diverse epidemiologic studies that
include European Americans, African Americans, Mexican Americans/Hispanics, Asians/Pacific
Islanders, and Native Americans. The rich phenotypic resources of PAGE studies provide a unique
opportunity for PheWAS as each genotyped variant can be tested for an association with the wide
array of phenotypic measurements available within the studies of PAGE, including prevalent and
incident status for multiple common clinical conditions and risk factors, as well as clinical
parameters and intermediate biomarkers. The results of PheWAS can be used to discover novel
relationships between SNPs, phenotypes, and networks of interrelated phenotypes; identify
pleiotropy; provide novel mechanistic insights; and foster hypothesis generation. The PAGE
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network has developed infrastructure to support and perform PheWAS in a high-throughput
manner. As implementing the PheWAS approach has presented several challenges, the
infrastructure and methodology, as well as insights gained in this project, are presented herein to
benefit the larger scientific community.
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Introduction
Much of the current focus on investigating the relationship between genetic variation and
disease is through the use of genome-wide association studies (GWAS). This approach has
been an important workhorse in genetic epidemiology for the past 5 years, as hundreds of
SNPs have been associated with the risk of complex diseases, such as type 2 diabetes and
osteoporosis, as well as with health-related intermediate traits such as elevated circulating
low density lipoprotein (LDL) cholesterol levels [Hindorff et al., 2009]. While these
associations have explained a small proportion of the heritability of these traits, they have
provided new leads toward a better understanding of the etiology and underlying biology of
disease [Lou et al., 2009; Moffatt et al., 2007; Musunuru et al., 2010].
One could argue that the current paradigm of GWAS is limited and suffers from important
shortcomings that inhibit the quest to further the understanding of the genetic contribution to
disease and traits. Despite the decrease in cost over time, GWAS are generally limited in
scope due to the cost of genotyping hundreds of thousands millions of SNPs for each
individual within a study. GWAS usually focus on a specific phenotypic outcome or series
of measurements. The focus on a limited phenotypic domain, such as the specific presence
or absence of a single disease in a GWAS, neglects the potential power gained through the
use of intermediate phenotypes, sub-phenotypes, biomarkers, and endophenotypes that may
more closely reflect a gene's mechanism, as well as the relationship between genetic
variation and multiple diseases and phenotypes (pleiotropy). Finally, most published GWAS
have been performed in populations of European-decent, and there is still little
characterization of the relationship between risk variants found in GWAS and disease and/or
phenotypes in other racial/ethnic groups.
A complementary approach to GWAS is the “phenome-wide association study” (PheWAS).
In PheWAS, the association between a number of common genetic variations and a wide
variety and large number of phenotypes are systematically characterized. Phenotypic/
genotypic resources amenable to the PheWAS approach are large-scale epidemiologic
studies with comprehensive collections of well-characterized phenotypic measurements and
environmental exposures recorded prospectively or retrospectively for thousands of
participants, such as the studies of the Population Architecture using Genomics and
Epidemiology (PAGE) network. Electronic medical record (EMR) resources coupled to
genotypic data can also be used for PheWAS, as they also contain rich resources of
phenotypic and genotypic information.
The EMR PheWAS approach was recently employed successfully by Denny et al. in a
proof-of-concept investigation using BioVU [Ritchie et al., 2010; Roden et al., 2008],
Vanderbilt University's biobank. In this PheWAS, five SNPs selected from the candidate
gene and GWAS literature were tested for associations with ICD-9 codes in several
thousand patients. The investigators were able to detect both the original associations (for
atrial fibrillation, Crohn's disease, carotid artery stenosis, coronary artery disease, multiple
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sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), as well as potentially
novel associations with other clinical outcomes/conditions in the EMR [Denny et al., 2010].
While ground-breaking, the sole PheWAS published in the literature has limitations that can
be addressed through the use of data from the studies of the (PAGE) network. Like initial
GWAS studies in the literature, the initial PheWAS focused primarily on binary disease
traits in European Americans from a clinic setting. The studies of PAGE that include
quantitative measurements, along with detailed disease status (incident or prevalent
depending on the study), and in most cases longitudinal follow-up information, have the
potential for increased power to detect genotypic/phenotypic relationships, as well as
characterize those relationships across race/ethnicity in a population-based manner. In
addition, the phenotypic measurements/outcomes of PAGE are measured using standardized
protocols, thus reducing measurement error and facilitating phenotype harmonization
between studies.
As stated above, the PheWAS analysis represents tests of association between a large
number of SNPs and phenotypes and traits available in PAGE, and is meant to be high-
throughput. As such, results of these first-pass analyses are considered hypothesis-
generating and require additional scrutiny before the findings are further considered for
follow-up. This hypothesis-generating exercise is unlike the directed, a priori hypothesis-
testing within PAGE whereby specific SNPs hypothesized to be associated with specific
phenotypes are tested only for those phenotypes. These a priori analyses include careful
phenotype harmonization for traits and outcomes that overlap across two or more PAGE
studies, as well as considerable investigation of the possible effect of covariates such as age,
gender, and environmental exposure(s) on the association between genetic variation and
phenotypic outcome. Unlike PheWAS, the advantage of these more carefully directed
analyses is the potential for identification and characterization of genetic modifiers and
accurate effect estimates. Also, because much effort has been expended to harmonize
phenotypes across studies at the initiation of the study, less effort is required to scrutinize
the results from these analyses compared with PheWAS. Despite the advantages of the more
a priori driven approach, the hypothesis generating PheWAS promises the opportunity to
identify unsuspected genotypic and phenotypic relationships for further investigation that
can include these forms of more thorough model characterization.
We describe herein the conceptual framework and design of the high-throughput, first-pass
analysis of the relationship between all risk variants genotyped thus far within PAGE and
the comprehensive phenotypic resources of the PAGE network, using this PheWAS
approach. The results of this scan across SNPs and phenotypes can be used to discover novel
relationships between SNPs, phenotypes, and networks of phenotypes to foster hypothesis
generation. This manuscript presents the infrastructure and methodology, as well as insights
gained in this PAGE-directed project, to benefit the larger scientific community.
PAGE
The PAGE network, funded by the National Human Genome Research Institute (NHGRI) in
2008, is a collaboration of four study sites, representing eight population-based studies, and
a coordinating center [Matise et al., 2010; in press]. All PAGE network studies are diverse
and include multiple racial/ethnic populations such as European Americans, African
Americans, Hispanic Americans, Asian Americans, and Native Americans. The PAGE
network consists of the Epidemiologic Architecture for Genes Linked to Environment
(EAGLE) study accessing the National Health and Nutritional Examination Surveys
(NHANES) [CDC, 2008; McQuillan et al., 2003], the Multiethnic Cohort Study (MEC)
[Kolonel et al., 2000], the Women's Health Initiative (WHI) [1998], and the Causal Variants
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Across the Life Course (CALiCo) that is a consortium of five cohort studies: Atherosclerosis
Risk in Communities [1989], Coronary Artery Disease Risk Development in Young Adults
(CARDIA) [Hughes et al., 1987], Cardiovascular Health Study (CHS) [Fried et al., 1991],
the Strong Heart Cohort Study [Lee et al., 1990], the Strong Heart Family Study, and the
Hispanic Community Health Study/Study of Latinos.
The primary focus of the PAGE network is the deep characterization of well-replicated
genetic risk variants identified in GWAS (∼400 to date) and their relationships to specific
phenotypes (e.g., lipids, diabetes, heart disease, cancers). Included in the characterization
process is (1) replication of the original association in a population of similar genetic
ancestry as the discovery population (which to date has been largely European-descent), (2)
generalization of the association to diverse populations such as African Americans,
Hispanics/Mexican Americans, American Indians, and other groups, (3) identification of
modifiers involved in gene-gene and gene-environment interactions, and (4) identification of
pleiotropy.
Table I shows several examples of phenotypes available in the studies of the PAGE network,
demonstrating the breadth of phenotypes across PAGE. Table II contains more information
about the following specific studies in this PheWAS from PAGE: WHI, EAGLE, MEC,
CALiCo-ARIC, CALiCo-CHS, and CALiCo-CARDIA. Additional details about the various
PAGE network studies are described in Matise et al. [2010; in press].
Methods for Implementing PheWAS in PAGE
The intent of PheWAS is to keep data processing high-throughput and relatively simple
while also annotating results with respect to quality control (general workflow in Fig. 1).
Study samples are genotyped and quality control procedures are followed at each site
independently. In addition all tests of association are calculated independently for each
study. All analyses are stratified by race/ethnicity, assuming an additive genetic model
where the homozygous genotype for the coded allele (reference allele chosen to be standard
across race/ethnicity) is coded as “2,” the heterozygous genotype coded as “1,” and the
homozygous genotype for the non-coded allele is coded as “0.” All data analyses in
PheWAS are standard logistic or linear regression analysis, dependent on design or whether
the phenotypes are continuous or binary. For variables with multiple categories, binning is
used to create new variables of the form “A vs. not A.” An example would be a
measurement of menarche, where study participants indicated where they fell within a series
of age ranges (9–10, 11–12, 13–14, etc.). In PheWAS, these results would be broken into the
age range of 9–10 vs. all other respondents, then a separate binary variable of the age range
of 11–12 vs. all other respondents, etc. In addition all continuous phenotypes are natural log
transformed after a constant of one is added to each quantitative trait measurement (as some
traits have values of “0”). After this transformation, the associations between all SNPs and
the transformed phenotypes are calculated. Data transformation will not be necessary for
some phenotypes; however, to maintain a high-throughput workflow, we perform the same
analyses on all continuous variables. Depending on the phenotype, results from linear
regressions on untransformed or transformed data can be later selected for interpretation and
further downstream analyses. Because each PAGE study site performs their own tests of
association, a variety of statistical packages are used, such as SAS version 9.2 and R version
2.11.0 (The R Foundation for Statistical Computing).
These analyses are not computationally intensive. The bigger challenge has been the
surrounding infrastructure necessary to run and process this many tests of associations in a
high-throughput fashion, which has necessitated the writing of software scripts/programs for
automation purposes. It became clear early in the PheWAS analyses that if all results were
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to be stored, combined, and shared across sites, the use of a standardized template for results
would be critical. Thus, the PAGE Coordinating Center developed a standard template for
SNP specific information, phenotype-specific information, and SNP-phenotype association
results. While using standardized templates has required each site to adapt their workflow to
format results into the template, this process has enabled the group to efficiently collect,
integrate, and analyze results across studies using a database.
Some basic quality control and result flagging procedures are also implemented by the
PAGE Coordinating Center when the individual results from different studies are submitted.
After the minimal curation steps described below, the results of associations can then be
examined and explored. For continuous variables, skewness of the data is a potential issue;
thus, degree of skewness is calculated for all continuous phenotypes. Skewness is also
calculated for transformed phenotypes. For most continuous traits, the outliers should not
impact the skewness of the data given the relatively large sample sizes for this study. Results
are “flagged” where the phenotype for a given set of linear regression results have an
absolute skewness value greater than 2 (|skewness| > 2) for the transformed and/or
untransformed phenotypes. Figure 2 shows the results of skewness before and after natural
log transformation for 351 continuous phenotypes within WHI, stratified by race/ethnicity
[African Americans (AA), European Americans (EA), Hispanics/Latinos (H)]. A horizontal
red line is at skewness of +/−2. Extreme skew values are visible in the untransformed data.
After data transformation, there is a shift of skewness away from extreme values.
For logistic regression and proportional hazards regression, odds ratios that are greater than
3 are flagged. While these results may be simply be very significant results, more likely, the
phenotype may need more inspection or the result may reflect poor estimation because of
small cell sizes. Results with an absolute value of beta divided by the standard deviation of
the phenotype used in the regression greater than 2.5 (|beta|/SD>2.5) are also flagged. Much
like the OR flag, these may be very significant results or perhaps some aspect of the
association that should be investigated further. Finally, regression results where the Hardy-
Weinberg Equilibrium (HWE) P-value of the SNP used in the regression is P<0.00001 are
flagged. Because PAGE is genotyping and characterizing SNPs originally described in
studies of European Americans, HWE may differ considerably if the population is admixed,
which is expected in many of the racial/ethnic groups studied in PAGE. Both genetic
ancestry (including admixture) and poor quality genotyping data are viable explanations for
deviations from HWE, both of which will require further inspection of the data. The process
of flagging results that do not pass certain criteria provides information to investigators so
that characteristics of specific phenotype, SNP genotype, and regression results can be easily
identified and more carefully considered before further data interpretation.
PheWAS Exploration
The generation of PheWAS results has the potential to provide unique research
opportunities, and one of the greatest challenges for PheWAS is not the implementation, but
rather the exploration and sharing of the results. Two avenues for disseminating and
exploring the PAGE PheWAS results are being used: dbGaP [Mailman et al., 2007] and the
PAGE Browser. For all analyses, aggregate data will be deposited into dbGAP for secondary
access by approved investigators. Furthermore, results will be available and searchable
through the PAGE browser. The PAGE browser is being developed by the PAGE
Coordinating Center as a tool for searching, filtering, and visualizing the results from
PheWAS, as well as other PAGE analyses. The PAGE browser includes information on
SNPs, phenotypes, study, ancestry and allows for PheWAS result filtering and display
options depending on the approach of interest, whether by study race, ethnicity or
phenotype. In addition to tabular data, the browser provides data visualization through the
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use of box plots and bar plots of summary statistics for quantitative and categorical
variables, forest plots that display confidence intervals and effect sizes for individual SNP-
phenotype results, and heat map plots indicating significance levels for large numbers of
SNP-phenotype results. The results are currently provided to PAGE investigators and PAGE
collaborators as a resource for investigating results on an SNP basis or phenotype basis
using the interactive browser tool developed by the PAGE Coordinating Center. In the
future, it is anticipated that outside investigators will be able to request access to the
resource as a way to generate hypotheses and insights that could direct further research into
genetic variation and phenotypes (Fig. 3).
Accounting for Multiple Testing in PheWAS–Using Replication in PAGE
Studies
A major challenge of PheWAS is adjusting for testing multiple hypotheses to protect from
type I errors. Much has been written concerning the multiple hypothesis testing problem in
GWAS and possible solutions [Rice et al., 2008]. However, unlike GWAS, PheWAS has an
added dimension to this problem: hundreds to thousands of phenotypes in addition to
potentially hundreds to thousands of SNPs. Depending on the total number of phenotypic
and genotypic variables and the number of racial/ethnic groups, hundreds of thousands to
millions of tests of association can be performed. As an example, in the WHI analysis there
were 95 SNPs, 1,514 phenotypes, and 5 racial/ethnic groups, resulting in ∼200,000 tests of
association. Calculation of the degree of false-positive results due to multiple hypothesis
testing is not straight-forward as there are potential correlations between phenotypes and
between SNPs. Also, a proportion of the genotype-phenotype correlations in the data set
represent already-known associations, and, as such, are positive controls rather than
experimental tests of association.
Despite the best efforts to determine the number of statistical tests performed, simple
adjustments based on these counts (such as a Bonferroni correction) may not be appropriate.
It is conceivable that alternative approaches such as false discovery rate, using principle
component analysis to determine the effective number of independent tests, or use of
permutation testing maybe utilized. However, within PAGE, only summary data are shared
between studies, resulting in significant challenges for implementing these forms multiple
testing correction. Thus, for the initial PAGE-PheWAS, in terms of prioritization of the first
set of results, we will be reporting the most statistically significant results that are observed
in 2 or more PAGE studies for the same SNP, phenotype and/or phenotype category, and
race/ethnicity. This requirement for replication between these independent PAGE data sets
lessens the chance of a result found by chance alone, particularly for results found to
replicate in more than two studies. Recall that PheWAS is a hypothesis generating exercise;
therefore, we are less concerned with the effect estimates and precision of the level of
significance. Our goal is to identify novel SNP-phenotype associations that have evidence of
replication in multiple PAGE studies, to consider in further in future studies. In addition,
because multiple race/ethnicities are represented within these data, we intend to describe the
presence/absence of generalization of PheWAS results across race/ethnicity. We define
generalization here as a significant association in more than one population, in addition to a
similar direction of effect.
Interpretation of Results
The ultimate challenge of PheWAS data is interpretation. Multiple approaches for
prioritizing and interpreting results are available for the exploration of results for PheWAS
(Fig. 4). Such approaches, as well as related questions when generating hypotheses from
these results, include the following:
Pendergrass et al. Page 6













Sorting Results by P-Value
As mentioned before, the most significant P-value results can be chosen for further
inspection and analysis. However, the most significant results may not be the results of
greatest interest depending on the phenotype and/or SNP.
Is the Result Expected or Unexpected?
One way of considering a result “expected,” is through observing replication of a previously
identified/reported genotype-phenotype association. Observing expected results provides
positive controls for this high-throughput experiment. Another example of results possibly
considered more “expected” are those for an SNP with a previously identified genotype-
phenotype association also associated with closely related and/or correlated phenotypes.
Although discovery of new gene-phenotype associations in PheWAS is both likely and
important, many of the findings from PheWAS may reflect the inter-relationships existing
among the phenotypes measured in epidemiological studies. In fact, some results may be
more about the relationship between particular phenotypes and disease outcomes than about
the impact of genetic variation on an independent phenotype. For example, a known type II
diabetes-associated SNP may be associated with type II diabetes in PheWAS, as well as with
related type II diabetes phenotypes such as fasting glucose levels, hyperinsulinemia, obesity,
and other diabetes-related phenotypes. Another example of a more “expected result” would
be for SNPs in high linkage disequilibrium (LD) with SNPs that have shown previously
identified genotype-phenotype associations with a phenotype used in the PheWAS analysis.
More “novel” results may occur in multiple ways and exemplify pleitropy As an example,
an SNP that has been significantly associated with asthma in the literature is found in
PheWAS to have an association with various blood cytokine levels, allergy skin tests results,
and fungal infections. While these are related phenotypes, this novel insight may provide
further information about the relationship between genetic variation and allergic/
inflammatory responses. If two phenotypes are not known to be related, such as might be
identified by observing significant associations between a single SNP and two apparently
independent diseases, this may indicate the impact of genetic variation on multiple unrelated
phenotypes (pleiotropy) or may expose a previously unknown relationship between two
phenotypic outcomes. An example of this would be that of a known diabetes-associated SNP
significantly associated with arthritis. This could potentially reflect the relationship between
autoimmunity, diabetes, and arthritis, and/or the contribution of genetic variation of that
gene to both phenotypes.
Correlation between Phenotypes
In an extension to some of the discussions of related phenotypes, one possible approach to
gain more information about and potentially uncover novel phenotypic relationships in
PheWAS is the calculation of correlation matrices for all continuous phenotypes within each
PAGE study. The results can then be explored in a heat-map, with higher correlations
(positive and negative) having a lighter color (yellow) and lower correlations in a darker
color (blue) (Fig. 5). Analogous to LD between SNPs, correlations between phenotypes can
be used to interpret results from tests of association as both significant association results
and strongly correlated phenotypes can be detected visually. In the example of Figure 5, the
PheWAS results and correlation matrix are from EAGLE/NHANES data and the plot shows
three areas of high correlation. For the allergy skin tests, measurements of the allergy
response were recorded for each participant tested. Among these measurements, there is a
high correlation between response to Alternaria alternata (a major plant pathogen) and
Bermuda grass. In a similar vein, the bone mineral content and bone mineral density
measurements in participants are highly correlated. Viewing these correlations has the
potential for providing information for interpretation of some of the association results.
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Relationships between various categorical variables and phenotypes can be investigated on a
case by case basis. For example, when comparing a specific continuous phenotype to a
binary trait, a simple t-test can be used to determine if there are different distributions of the
continuous variable between cases and controls. Likewise, certain binary traits can be
investigated to see if there is a common overlap between cases/controls for one binary
variable vs. another. This is a potential option to explore, not a necessary component of the
PheWAS workflow.
Race/Ethnicity
Most GWAS and candidate gene studies to date have been performed using populations of
European-descent. All PheWAS analyses here are being performed in multiple race/
ethnicities; thus, results can be characterized across race/ethnicities to better understand how
specific associations may or may not generalize across populations of differing genetic
ancestry.
After initial exploration of PheWAS results, further work will be necessary to fully
characterize phenotype-genotype associations of interest, and PAGE has the resources and
expertise for follow through analyses for specific PheWAS results. In the case of results
where the SNP and phenotype exist across two or more studies, initial follow-up work
includes: determining the consistency of direction-of-effect, examining the P-values across
the studies, examining how the results vary across race/ethnicity, and determining the
sample size and resultant power across the studies. Further work includes directed,
traditional hypothesis-testing, as performed already within PAGE for previously known
genotype-phenotype associations, such as the work of the PAGE Lipids Project Group
[Dumitrescu et al., 2010; submitted]. For phenotype-genotype associations that only exist in
a single PAGE study because either the SNP or phenotype was not evaluated in other PAGE
studies, replication of the result in a data set outside the PAGE network would be useful. An
example would be replicating PheWAS cardiac trait results using data from the Framingham
Heart Study GWAS [Cupples et al., 2007]. In addition, as PAGE moves forward, an SNP
found to be of interest may become a target SNP for future a priori driven work in PAGE,
and may be proposed for study-wide genotyping, increasing the sample sizes available for
PAGE analysis.
Future Directions for PheWAS
Using the information gained from the broad interrogation of interrelated phenotypes and
the relationship to genetic variation provides an opportunity to consider and explore the
networks of phenotypes that comprise disease, as well as identify pleiotropy. The emerging
field of phenomics has been championing “deep-phenotyping,” the broad collection of
diverse and detailed phenotypic information and investigating network structure among
those arrays of phenotypes [Bilder et al., 2009; Ghebranious et al., 2007; Rzhetsky et al.,
2007]. There have been discussions of approaches for relating these phenotypic data back to
genotypic variation [Jones et al., 2005], as well as visualization and interpretation of
phenotypic networks [Lanktree et al., 2010; Rzhetsky et al., 2007]. PheWAS is novel in the
promise of harnessing and interrogating both phenotypic structure and large numbers of
genotypes together in a high-throughput fashion, truly allowing for the investigation of the
larger structure of and interrelationships between phenotypic and genotypic diversity.
Throughout the initial development of PheWAS in PAGE, approaches are being developed
for both grouping phenotypes, as well as characterizing phenotypic structure. Thus, there is
current work within PAGE to use computational algorithms to bring together related
phenotypes across studies of PAGE. As mentioned previously, several known phenotype
relationships exist between the phenotypes, intermediate phenotypes, sub-phenotypes,
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biomarkers, and endophenotypes that exist within the studies of PAGE. One approach for
characterizing some of the relationships between phenotypes within these data is the
possibility of visualizing correlations between continuous phenotypes. Another approach is
to group related phenotypes into categories. This structure can then be related back to
significant genotype-phenotype associations, potentially providing more information about
the larger relationship between genetic variation and phenotypic variability. An additional
step is to link the phenotypes of PAGE to specific phenotypic domains and data resources
that have been developed that characterize phenotype relationships, as well as resources that
summarize and monitor published GWAS results [Hindorff et al., 2009]. Through linking to
these resources that include automated text mining and data summation of what has been
published to date, further phenotypic structure and phenotype-genotype relationships can
provide additional information when interpreting and delving into PheWAS results. Some
approaches for mapping these phenotype networks are starting to be discussed and
developed in the field of phenomics [Lanktree et al., 2010; Rzhetsky et al., 2007].
Strengths and Limitations of the PheWAS Approach
The main strength of this approach is the potential to make novel discoveries and to identify
new relationships between phenotypes and genetic variation, different from the more
common approach of examining the relationship between one or a handful of disease
outcomes/phenotypes and genetic variation. In addition, PheWAS analyses include known
genotype-phenotype associations in addition to novel associations, and these known
associations serve as “positive controls” for this high-throughput analysis. Another strength
of this PAGE-PheWAS is the diversity of the PAGE studies, as both novel and known
genotype-phenotype associations can be examined across multiple racial/ethnic groups for
generalization. As this work is being performed in parallel across multiple groups, as long as
both the genotype and phenotype exist in more than one study, replication of associations
across PAGE studies is possible. Heterogeneity in how some phenotypes across PAGE
studies are measured is a potential limitation for the PAGE-PheWAS. However, PheWAS is
intended to be exploratory and significant results of interest can be investigated further in
future work with careful phenotype harmonization.
As previously mentioned, a major limitation of PheWAS is the potential for identifying
false-positive associations, as thousands of genotype-phenotype relationships are being
investigated. Sample sizes do differ between the various studies of PAGE, which can impact
power and the detection of replication across studies. Another limitation of the PAGE
PheWAS analysis is related to the SNP selection process. While the number of SNPs
genotyped in Year 1 of PAGE is relatively large (currently ∼400, and numbers will increase
over time as more SNPs are genotyped), the genetic variation studied is much more limited
than that of GWAS. The SNPs used in PAGE PheWAS are well-characterized SNPs, but are
selected because of their well-replicated previous association with specific phenotypes (for
example, LDL cholesterol-associated SNPs). One way to increase the SNP coverage is to
perform a GWAS with an extremely rich phenotype data set (PheWAS-GWAS). While this
would add additional complexity to the PheWAS analysis, this would truly be the optimal
way to investigate both a comprehensive set of SNPs and phenotypes.
Conclusions
The steps and workflow described here have been developed and defined from the initial
work on the PAGE PheWAS project. PheWAS is a novel resource for mining
phenotypically rich data sets to provide insight on the interrelationships between genetic
variation and networks of phenotypes. The nature of investigating a large number of
phenotypes in PheWAS, ranging from outcome phenotypes, such as disease status to
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intermediate phenotypes, biomarkers, quantitative traits, and risk factors, has the potential
for defining a more complete picture of genetic variation and disease, generating
hypotheses, and identifying pleiotropy.
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Workflow for PheWAS. Study samples are genotyped and quality control procedures are
followed at each site independently. In addition all tests of association are calculated
independently for each study. The PheWAS quality control step flags results as described in
the text. As a resource for PAGE investigators, the most significant associations from
PheWAS can be explored in the PAGE browser across race/ethnicity (green). For
investigators outside of PAGE, aggregate data from PheWAS will be available via dbGAP.
For the PAGE PheWAS analysis, results for six studies will be used and where SNPs and
phenotypes exist across data sets, replication will be sought (blue). Significant results can
then be selectively investigated and characterized further.
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Skewness and transformation. Skewness measured for 351 phenotypes, stratified by race/
ethnicity, before transformation and after adding 1 then natural log transforming each
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continuous variable. Results are presented in the upper and lower panel for: African
American (AA) untransformed, AA transformed, European American (EA) untransformed,
EA transformed, Hispanic (H) untransformed, H transformed, Asian Pacific Islander (API)
transformed, API untransformed, American Indians (AI) untransformed, AI transformed.
Horizontal red lines are at positive two and negative two. The lower panel shows a “zoomed
in” version of the upper panel, showing the compression of points after the transformation of
variables.
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PAGE browser. Different views of the PAGE browser provide different possibilities for
investigators examining the results of the analyses. (A) The heat map view, where
association results are plotted in a “heat map” format. SNPs are along x-axis, phenotypes are
along the y-axis. The color of each cell corresponding to the individual SNP-by-Phenotype
results is either a shade of yellow or red if the direction of effect is positive, or a shade of
green or blue if the direction of the effect is negative. Increasing significance is indicated by
shade respective to the direction of effect. (B) Phenotypic summary information across race/
ethnicity. The box-plots show the 1st, 2nd, and 3rd quantiles by genotype for quantitative
phenotypes. (C) For associations, forest plots are available, stratified across race/ethnicity.
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Approaches for visualizing and interpreting results of PheWAS. There are multiple ways the
results of PheWAS can be explored. Correlations between quantitative phenotypes can be
calculated to investigate some of the relationships between phenotypes. Results across race/
ethnicity can be compared. Results can be ranked by significance and then explored one at a
time for further replication and characterization with further phenotype harmonization. The
expected/unexpected nature of results can also be investigated, as some genotype-phenotype
associations are previously known. Grouping of phenotypes is possible, as well as further
exploration of phenotypic structure.
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Correlation Heat Map from EAGLE phenotypic and PheWAS data. Phenotypes are along
the x-axis. The middle track shows the −log10(P-value) results for each genotype-phenotype
test of association. Below the P-value significance track, a heat map of correlation results is
plotted. Pearson correlations between quantitative phenotypes are calculated and the
absolute value of each correlation is plotted. Relative significance is displayed by the shade
of the color (that is, the more significant the correlation, the brighter yellow the cell). In this
figure, bone mineral content and bone mineral density measurements are correlated, along
with body mass index.
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TABLE I
Example survey categories, measurements, and phenotypes within PAGE-PheWAS
Example survey categories Biomarker, cancer, renal function, neurology, nutrition, infectious disease, inflammation
Example measurements Respiratory, skin, bone, muscle, joint, speech, hearing, biochemistry tests, cardiovascular, anthropometric, ocular
Example phenotypes Systolic and diastolic blood pressure, body mass index, gingival bleeding, number tooth carries, apolipoprotein B
level, wheal length alternaria allergy scratch test, plasma glucose level, fibrinogen level, monocyte number, QRS
interval, QT interval, platelet count, forced vital capacity (FVC), self-reported presence/absence diabetes, self-
reported presence/absence osteoporosis, self-reported presence/absence cardiovascular disease, follicle
stimulating hormone, tympanometry measurement, balance measurement, bone mineral density, keratometry,
self-reported presence/absence eczema, glycohemoglobin measurement, self-reported presence/absence asthma,
cotinine levels, c-reactive protein level, HDL levels, LDL Levels, white blood cell count, hemoglobin, hematocrit,
urine creatinine, serum folate, serum globulin, luteinizing hormone
Results reported SNP ID, beta (linear regression), P-value, odds ratios (logistic regression), allele frequencies, associated
phenotype and previously associated phenotype, phenotype summary information specific to the regression
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